Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: Patients treated in the in- or outpatient setting at the University Hospital Basel with detection of carbapenemase-producing bacteria in any screening or clinical sample from January 1st , 2008 until December 31st , 2028

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Infections With CPB

Being tested

data collection for demographic data, data collection for clinical data, data collection for treatment data, data collection for microbiological data

Keywords

Carbapenemase-producing Klebsiella pneumoniae, antibiotic resistancy, infections with Carbapenemase-producing Bacteria (CPB), Carbapenemase-producing Bacteria

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• data collection for demographic dataOther

  data collection for demographic data (age, gender, hospital admission and discharge date, length of stay, hospitalization prior to current hospital stay (acute care facilities, long-term healthcare centres, nursing homes), discharge destination, outcome, cause of death, travel history, previous exposure to antibiotics and proton pump Inhibitors)

• data collection for clinical dataOther

  data collection for clinical data (comorbidities, Charlson Comorbidity Index, immunosuppressive treatment, date of diagnosis of CPB, days between hospital admission and diagnosis of CPB, type of consecutive infection, indwelling vascular hardware, urinary catheterization, surgical therapies)

• data collection for treatment dataOther

  data collection for treatment data (antibiotic therapy, immunosuppressive therapy, concomitant medication)

• data collection for microbiological dataOther

  data collection for microbiological data (species of CPB, type of sample, date of sample, history of colonization or infection with any antibiotic resistant pathogen)

What is being measured

The primary outcome is the main question the study is designed to answer.

1. incidence of CPB at the University Hospital Basel (number)

   incidence of CPB at the University Hospital Basel (number)

   Measured: from January 1st , 2008 until December 31st, 2028

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted23 Sep 2019
2. Study start22 Aug 2019
3. Primary completion30 Jun 2029 (estimated)
4. Study completion30 Jun 2029 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Infections With CPBStudies of the same condition, open and under way.
• More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.